Stock Events

Stock Events

Acrivon Therapeutics 

$2.20
42
-$0.01-0.45% Monday 20:00
-$0.00-0.14%Monday 23:32After hours

Statistics

Day High
2.2
Day Low
2.2
52W High
3.56
52W Low
1.27
Volume
5,513
Avg. Volume
-
Mkt Cap
94.28M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.66
-0.59
-0.51
-0.43
Expected EPS
-0.451667
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2021
2022
2023
2024
2025
0Revenue
-77.91MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ACRV. It's not an investment recommendation.
NVIDIA
9
NVDA
Microsoft
8
MSFT
AMD
6
AMD
SoFi Technologies
6
SOFI

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bristol-Myers Squibb
BMY
Mkt Cap136.88B
Bristol Myers Squibb is a leading biopharmaceutical company that competes with Acrivon in the oncology and hematology market, particularly in developing treatments for various cancers.
Merck
MRK
Mkt Cap376.37B
Merck & Co., Inc. is a global healthcare company that competes with Acrivon Therapeutics in the field of cancer research and development, offering innovative cancer treatments and therapies.
Pfizer
PFE
Mkt Cap159.99B
Pfizer Inc. is a pharmaceutical and biotechnology corporation that competes with Acrivon in the development and commercialization of drugs for various diseases, including cancer.
Novartis
NVS
Mkt Cap301.95B
Novartis AG is a multinational pharmaceutical company that competes with Acrivon Therapeutics in researching and developing innovative therapies for cancer and other diseases.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a healthcare company that competes with Acrivon in the oncology sector, focusing on developing cancer treatments and diagnostics.
Lilly(Eli) &
LLY
Mkt Cap1.12T
Eli Lilly and Company is a global pharmaceutical company that competes with Acrivon Therapeutics in developing drugs for cancer and other health conditions.
Astrazeneca
AZN
Mkt Cap257.42B
AstraZeneca PLC is a biopharmaceutical company that competes with Acrivon in the oncology area, working on developing treatments for various types of cancer.
Gilead Sciences
GILD
Mkt Cap181.18B
Gilead Sciences, Inc. is a biopharmaceutical company that competes with Acrivon Therapeutics in developing innovative therapies for cancer, among other diseases.
AMGEN
AMGN
Mkt Cap237.52B
Amgen Inc. is a biotechnology company that competes with Acrivon in the field of oncology, focusing on cancer drug development and personalized medicine.
Regeneron Pharmaceuticals
REGN
Mkt Cap85.87B
Regeneron Pharmaceuticals, Inc. is a biotechnology company that competes with Acrivon Therapeutics in developing treatments for cancer and other serious diseases.

About

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1; ACR-2316 a selective, dual WEE1/PKMYT1 inhibitor; and ACR-6840, a development candidate targeting CDK11. It has one reportable segment focused on the research and development of precision oncology therapies.
Show more...
CEO
Peter Blume-Jensen
Employees
76
Country
United States
ISIN
US0048901096

Listings

XNAS
US
ACRV
BOATS
BOATS
ACRV.BOATS

0 Comments

Share your thoughts

FAQ

What is Acrivon Therapeutics stock price today?▼
The current price of ACRV is $2.20 USD — it has decreased by -0.45% in the past 24 hours. Watch Acrivon Therapeutics stock price performance more closely on the chart.
What is Acrivon Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Acrivon Therapeutics stocks are traded under the ticker ACRV.
Is Acrivon Therapeutics stock price growing?▼
ACRV stock has risen by +7.32% compared to the previous week, the month change is a +37.5% rise, over the last year Acrivon Therapeutics has showed a +65.41% increase.
What is Acrivon Therapeutics market cap?▼
Today Acrivon Therapeutics has the market capitalization of 94.28M
When is the next Acrivon Therapeutics earnings date?▼
Acrivon Therapeutics is going to release the next earnings report on November 12, 2026.
What were Acrivon Therapeutics earnings last quarter?▼
ACRV earnings for the last quarter are -0.43 USD per share, whereas the estimation was -0.5 USD resulting in a +14.38% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Acrivon Therapeutics revenue for the last year?▼
Acrivon Therapeutics revenue for the last year amounts to 0 USD.
What is Acrivon Therapeutics net income for the last year?▼
ACRV net income for the last year is -77.91M USD.
How many employees does Acrivon Therapeutics have?▼
As of August 25, 2026, the company has 76 employees.
In which sector is Acrivon Therapeutics located?▼
Acrivon Therapeutics operates in the Health & Wellness sector.
When did Acrivon Therapeutics complete a stock split?▼
Acrivon Therapeutics has not had any recent stock splits.
Where is Acrivon Therapeutics headquartered?▼
Acrivon Therapeutics is headquartered in WATERTOWN, United States.